Grünenthal is an international family-owned pharmaceutical company with its head office in Germany. We specialise in the field of pain therapy and contraception and tread trend-setting paths.
The development and marketing of innovative formulations for established active substances are aspects on which we particularly focus. The company, founded in 1946, markets its products in approx. 100 countries; in addition Grünenthal is internationally active with seven production sites and companies in 29 countries. Grünenthal employs approximately 4800 people world-wide - 1900 in Germany.
Together with highly specialised partners we are pressing on with the research and development of new active substances. For this we are concentrating on selected indications and the latest technological developments. We are intensively searching for innovative ways of improving pain, pain relief and reducing side-effects.


